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In their natural habitat, yeast cells are constantly challenged by changing
environmental conditions and a ﬁerce competition for limiting resources. To
thrive under such conditions, cells need to adapt and divide quickly, and be
able to neutralize the toxic compounds secreted by their neighbors. Proteins
like the pathogen-related yeast, Pry proteins, which belong to the large CAP/
SCP/TAPS superfamily, may have an important role in this function. CAP
proteins are conserved from yeast to man and are characterized by a unique
aba sandwich fold. They are mostly secreted glycoproteins and have been
implicated in many different physiological processes including pathogen
defense, virulence, venom toxicity, and sperm maturation. Yeast members of
this family bind and export sterols as well as fatty acids, and they render
cells resistant to eugenol, an antimicrobial compound present in clove oil.
CAP family members might thus exert their various physiological functions
through binding, sequestration, and neutralization of such small hydrophobic
compounds.
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The CAP proteins constitute a large protein superfam-
ily with members found in all kingdoms of life. The
family is named after three founding members: Cys-
teine-rich secretory proteins (CRISP), antigen 5 (Ag5),
and pathogenesis-related protein 1 (PR-1), and is also
known as SCP (sperm coating protein) or TAPS (Tpx-
1/Ag5/PR-1/Sc7). It presently is constituted of 13 584
members in 2863 species (Pfam PF00188). CAP pro-
teins are implicated in many fundamental biological
processes, ranging from immune defense in mammals
and plants, sperm maturation and fertilization, pros-
tate and brain cancer, pathogen virulence and venom
toxicity. CAP family members are mostly secreted gly-
coproteins that are very stable in the extracellular
ﬂuid. Even though CAP proteins are intensely studied,
their mode of action has remained elusive (for review
see ref. [1–3]).
Using yeast as a model organism, we could recently
show that CAP proteins bind sterols as well as fatty
acids at two independent binding sites. Through bind-
ing to these secreted proteins, these hydrophobic com-
pounds are solubilized and transported out of the cell.
This lipid export function of the CAP proteins is
essential under speciﬁc growth conditions, for example,
in cells that accumulate high levels of free fatty acids.
On the other hand, cells lacking these proteins are
hypersensitive to eugenol, an antimicrobial compound
present in clove oil. Eugenol directly competes with
cholesterol for binding to at least one of the yeast
CAP protein, Pry1, in vitro, indicating that eugenol
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and possibly other structurally related small hydropho-
bic compounds bind to the same site on the protein as
cholesterol. These results suggest that CAP proteins
may function both intra- as well as extracellularly to
bind and thereby neutralize potential membrane per-
turbing hydrophobic compounds in yeast. In mam-
malian cells, these proteins may bind and neutralize
immune modulating lipid signals, such as eicosanoids,
thereby allowing insects to prolong their blood feed
and parasites to evade the immune reaction of their
host. Additionally, in plants, the sterol sequestering
function of these proteins suppresses growth of sterol-
auxotrophic pathogens. Thus, CAP proteins may exert
a variety of physiological functions through a common
mode of action, the sequestration of small hydrophobic
compounds.
An example of the functional diversity
within the CAP superfamily: the
founding members
The pioneer of the three founding members of the
CAP superfamily was identiﬁed in 1970 when proteins
induced upon viral infection of tobacco leaves were
ﬁrst identiﬁed and characterized [4]. These pathogene-
sis-related (PR) proteins were initially numbered
according to their molecular mass upon SDS gel elec-
trophoresis and have subsequently been classiﬁed into
17 families, with PR-1 being the smallest with 14 kD.
Some of these PR proteins have glucanase activity
(PR-2), whereas others have chitinase (PR-3,4,8,11),
protease inhibitor (PR-6), peroxidase (PR-9), or
ribonuclease activity (PR-10), and thus serve as a
direct line of defense against fungal and bacterial
pathogens [5,6]. The only PR family for which no bio-
chemical function was known was PR-1, even though
speciﬁc members of the tobacco and tomato family
displayed antimicrobial activity against oomycete
pathogens and their overexpression conferred patho-
gen resistance. Yet, their mechanism of action
remained to be characterized [7–9].
Antigen 5, the second founding member of the CAP
superfamily is one of the most abundant and immuno-
genic protein present in the venom-secretory ducts of
stinging insects. Ag5 proteins form part of a cocktail
of salivary proteins that are believed to function either
in suppression of the host immune system or in pre-
vention of blood clotting to prolong feeding [10]. The
biochemical activity of Ag5, however, is not known.
Cysteine-rich secretory proteins, the third and last
founding members of the CAP superfamily are highly
enriched in the mammalian reproductive tract and in
the venom-secretory ducts of snakes, lizards, and other
vertebrates. CRISPs are two-domain proteins with an
N-terminal CAP domain and a C-terminal cysteine-
rich domain (CRD) containing a conserved spacing of
up to 16 Cys residues, which adopts a fold that is simi-
lar to potassium channel inhibitors and thus may mod-
ulate the activity of ion channels [11]. CRISPs are
likely to be dual function proteins with an activity
associated with both the N-terminal CAP domain and
the C-terminal CRD domain [1,12].
Cysteine-rich secretory proteins 3 transcription is
dramatically upregulated in prostate cancer, for which
it serves as a biomarker [13]. Upregulation of other
CAP family members in malignant cells indicates a
possible role of these proteins in cancer progression.
For example, glioma pathogenesis-related protein 1
(GLIPR1) and GLIPR2 are among the most highly
induced transcripts in human gliomas. These astrocyte-
derived brain tumors account for the majority (65%)
of all brain tumors [14]. These observations raise the
possibility that CAP proteins may serve as diagnostic
tools and ultimately perhaps even as therapeutic tar-
gets [1].
CAP family proteins adopt a unique
aba sandwich fold
The CAP proteins share limited sequence identity with
each other but they share two signature PROSITE-
recognized motifs, referred to as CRISP motifs (http://
prosite.expasy.org/) (Fig. 1). The NMR structure of
plant PR-1 protein and the crystal structures of several
CAP proteins have been determined. They revealed that
these conserved sequence motifs are present in a small
and structurally conserved 17–21 kD CAP domain,
which adopts a unique aba sandwich fold. The tight
packing of the a-helices on both sides of the central b-
sheet results in a compact, bipartite molecular core,
which is stabilized by hydrophobic interactions, multiple
hydrogen bonds, and by two highly conserved disulﬁde
bonds. These features are thought to provide the ther-
mal, pH, and proteolytic stability reported for CAP pro-
teins, consistent with the structural requirements of an
extracellular function of these proteins. In addition, the
surface of the CAP domain displays a large cavity that
might be important for their interaction with other pro-
teins (Fig. 2) [11,15–18].
The strong structural conservation of the CAP
domain early on suggested a common mode of action
of these proteins in plant pathogen defense and brain
immune cells [16]. Although a large number of pro-
teins within this superfamily contain a CAP domain in
isolation, such as the venom allergen Ag5 or the plant








N- or C-terminal extensions, which are thought to
modulate the function of the CAP domain and thereby
may alter target speciﬁcity and thus the physiological
response [1].
Pathogen-related in yeast, Pry
proteins bind and export sterols
We have previously shown that sterols, sterol precur-
sors, and other small hydrophobic compounds are sub-
ject to an acetylation/deacetylation cycle and have
proposed that this cycle acts as a lipid detoxiﬁcation
pathway because acetylated sterols and sterol precur-
sors are excreted from the cells [19]. At that time, we
also proposed that the secretion of such hydrophobic
compounds is likely to require proteins that bind and
solubilize these lipids. These proteins could then be
identiﬁed as the Pathogen Related in Yeast, Pry
proteins, that is, the yeast CAP family members [20].
The yeast genome codes for three different Pry pro-
teins. Pry1 and Pry2 are secreted glycoproteins,
whereas Pry3 encodes a glycosylphosphatidyl inositol
(GPI)-anchored cell wall protein [21]. These three Pry
proteins share a redundant function in secretion of
cholesteryl acetate, but a pry1Δ pry2Δ double mutant
has an almost complete block in sterol secretion. Puri-
ﬁed Pry1 and Pry2 bind free and acetylated sterols
in vitro. Sterol binding is saturable with a dissociation
constant in the low micromolar range (Kd of
~ 0.7 lM), and the CAP domain of Pry1 is necessary
and sufﬁcient for sterol binding in vitro and in vivo
[20,22]. Pry proteins thus bind sterols with an afﬁnity
that is comparable to that of other sterol-binding pro-
teins such as the yeast member of the oxysterol-bind-
ing protein family, Osh4 (Kd of ~ 0.3 lM), the
steroidogenic acute regulatory protein StAR/STARD1
Fig. 1. Sequence alignment of yeast CAP proteins Pry1, 2, and 3 with the founding members of the CAP superfamily, CRISP3, Ag5, and PR-1.
Partial sequence alignment of the core set of CAP proteins around the CAP domain, PR-1 (Arabidopsis thaliana), Ag5 (Vespula vulgaris),
CRISP3 (Homo sapiens), Pry1, 2, and 3 (Saccharomyces cerevisiae). The degree of amino acid conservation is indicated by the bars in the line
on top. Secondary structure elements are indicated by the colored lines below the sequence alignment; magenta, a-helix; yellow, b-sheet.
The extent of the CAP domain is indicated by the red bar. The two signature PROSITE-recognized motifs, the CRISP motifs, are boxed in blue.
The alignment was generated using MAFFT, and illustrated using GENEIOUS 10.2.3 (Biomatters software, Auckland, New Zealand).
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Fig. 2. Structure of the CAP domain of yeast Pry1. (A) Ribbon drawing of the CAP domain of Pry1 (Pdb: 5JYS). a-helices are shown in red,
b-strands in cyan. Disulﬁde bonds are shown as stick models in magenta. (B) Space-ﬁlling representation of the CAP domain of Pry1








(Kd of ~ 0.03 lM), or Niemann–Pick Disease Type C2
protein NPC2 (Kd of ~ 0.1 lM) [23–25].
Most importantly, the block in sterol secretion of a
pry1Δ pry2Δ double mutant is rescued by expression
of CRISP2, a mammalian CAP superfamily member
that is expressed in the testis and epididymis and par-
ticipates in sperm–egg interaction during fertilization,
indicating that sterol binding is a conserved feature of
CAP superfamily members [1,20,26]. Similarly, expres-
sion of SmVAL4, a CAP superfamily member from
the human parasite, Schistosoma mansoni, in yeast cells
lacking Pry function rescues their block in sterol
export and puriﬁed SmVal4 binds cholesterol in vitro
[27]. Schistosoma is a pathogenic ﬂatworm, causing
snail fever (bilharzia), which, after malaria, is the sec-
ond most devastating parasitic disease, affecting more
than 200 million people worldwide. The CAP proteins
of these organisms are potential vaccine candidates
[28,29].
To characterize the mode of sterol binding of these
proteins in more detail, we performed computational
modeling studies. These homology models revealed the
presence of a ﬂexible loop within the CAP domain of
Pry1, which could potentially displace to bind choles-
terol. This loop harbors a so called caveolin-binding
motif, that is, a motif containing a short stretch of
aromatic amino acids [30]. The caveolin-binding motif
in the human CAP superfamily member, GLIPR2/
GAPR1, had previously been shown to interact with
caveolin by immunoprecipitation [31]. Mutations in the
ﬂexible loop region of Pry1 abrogate binding of acety-
lated sterols in vitro as well as in vivo, indicating that
this region is indeed important for ligand binding [32]
(Fig. 3A,B). Consistent with this notion, CAP family
member from the cacao pathogen Moniliophthora
perniciosa that do not bind cholesterol can be con-
verted into sterol binders by a single point mutation in
their caveolin-binding motif [33]. The mode of sterol
binding by Pry1 is thus different from that of other
cytosolic sterol-binding proteins such as Osh4, StAR/
STARD1, or NPC2, which all bind the lipid in a deep
hydrophobic tunnel buried inside the protein [23,34–36].
The CAP domain of Pry1 forms dimers in solution
and the structure revealed the presence of 1,4-dioxane
in the putative cholesterol-binding site [22]. However,
so far, no crystals grown in the presence of cholesterol
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Fig. 3. Proposed mode of ligand binding
by the CAP domain. (A) Ribbon drawing of
the CAP domain of Pry1 showing binding
of cholesterol (blue) and palmitate (green),
the caveolin-binding motif is indicated in
orange. The two disulﬁde bonds are
shown as stick models in magenta. For
illustration purposes, the cholesterol
molecule was manually positioned so as
to ﬁll optimally the open cavity, adapted
from [32]. The position of palmitate
corresponds to that observed in the crystal
structure of tablysin-15 [38]. Oxygen
atoms on the two ligands are indicated in
red. (B) Space-ﬁlling representation of the
Pry1 CAP domain with the two bound
ligands. Same color code as in panel A.
Generated using PYMOL. (C, D) Binding of









could be obtained to conﬁrm the putative mode of
action at the structural level.
Mapping the structural requirements on the part of
the ligand for binding to Pry1 revealed that the alipha-
tic side chain of cholesterol and related sterols is
important for binding, whereas the 3-hydroxyl group
of the sterol appears dispensable [37]. The CAP
domain thus binds the mammalian cholesterol, the
fungal ergosterol and the plant stigmasterol, but it
does not bind steroids, which lack the aliphatic side
chain.
Pry1 and Pry2 bind eugenol and possibly other
related small hydrophobic compounds. Eugenol is a
member of the allylbenzene class of compounds that is
present in clove oil, nutmeg, cinnamon, and bay leaf,
and is used as a local antiseptic and anesthetic. Yeast
mutants lacking Pry function are eugenol hypersensi-
tive, whereas the overexpression of Pry1, Pry2 or the
mammalian CRISP2 renders them eugenol resistant
[20]. Eugenol competes with cholesterol for binding to
Pry1 and Pry2, indicating that the binding sites for the
two lipids are overlapping, which is consistent with
molecular modeling studies (Fig. 3C,D) [20,37]. These
data thus indicate that CAP proteins might not only
promote the secretion of potentially harmful
hydrophobic compounds, such as, for example, inter-
mediates in sterol biosynthesis, but they might also
sequester such compounds when present in the extra-
cellular space [19].
Pry proteins bind and export fatty
acids
The saliva of blood-feeding arthropods contains
proteins, peptides, and small molecules that inhibit
host systems of inﬂammation and hemostasis. One of
these proteins, a CAP protein from the horseﬂy
Tabanus yao, tablysin-15, is a very potent inhibitor of
platelet and endothelial cell function. Interestingly, the
structure of the CAP domain of tablysin-15 revealed a
hydrophobic channel that was occupied by a fatty acid
and the delipidated protein binds proinﬂammatory leu-
kotrienes with submicromolar afﬁnity, suggesting that
tablysin-15 acts as a scavenger of eicosanoids [38].
Eicosanoids are released in the skin by activated mast
cells, causing pain and itching, and they elicit changes
in the vascular permeability at the site of an
insect bite.
Computational modeling and sequence comparison
revealed that the hydrophobic channel described for
tablysin-15 is conserved in Pry1, suggesting that Pry1
may also be able to bind fatty acids (Fig. 3A,B).
In vitro binding assays with puriﬁed Pry1 conﬁrmed
that the protein binds [3H]-palmitic acid with a sat-
urable binding kinetics and an apparent Kd of 112 lM.
Interestingly, the two lipid-binding sites on Pry1, the
sterol- and the fatty acid-binding sites, are distinct and
nonoverlapping because binding to [3H]-palmitic acid
cannot be competed for by addition of unlabeled
cholesterol and vice versa [39].
To test whether Pry1 also binds fatty acids in vivo
and to determine whether this lipid-binding function is
physiologically relevant, we took advantage of the
observation that mutant cells lacking two major acyl-
CoA synthases, Faa1 and Faa4, secrete high levels of
fatty acids into the culture medium [40]. This secretion
of fatty acids required Pry function since transcrip-
tional shut off of PRY1 in a pry2Δ pry3Δ faa1Δ faa4Δ
mutant background reduced the levels of exported
fatty acids and instead resulted in their intracellular
accumulation [39].
The function of Pry to export fatty acids under
these conditions is essential, since a complete deletion
of all three PRY genes in an faa1Δ faa4Δ mutant
background renders cells inviable [39]. This system
thus allows for an in vivo assay to test various CAP
family members for their ability to bind and export
fatty acids. Pry proteins, to our knowledge, are the
ﬁrst proteins identiﬁed to promote the secretion of free
fatty acids. They thus differ from the family of abun-
dantly expressed intracellular fatty acid-binding pro-
teins (FABP), which reversibly bind hydrophobic
ligand, such as saturated and unsaturated long-chain
fatty acids, eicosanoids and other lipids, with high
afﬁnity [41,42]. Albumins, on the other hand, consti-
tute a class of well-characterized secreted FABP, but
these proteins are generally believed to bind and solu-
bilize fatty acids only once they are secreted into the
circulation [43,44].
Pry3 affects the yeast mating reaction
Among the three members of the Pathogen-Related
Yeast proteins, Pry3 stands out because: (a) it is more
than twice as long as either Pry1 or Pry2, (b) it has its
CAP domain in its N-terminal part followed by a long
Ser/Thr-rich region, whereas Pry1 and Pry2 have the
CAP domain in the C-terminal part of the protein,
and (c) Pry3 not only has an N-terminal signal
sequence (SS) but also an x-site that directs attach-
ment of a C-terminal GPI anchor [45] (Fig. 4). The
post-translationally modiﬁed Pry3 is retained in the
yeast cell wall by attachment to b-1,6-glucans via its
GPI remnant [21,45]. Interestingly, this extracellular
protein has been implicated in the mating reaction,








In response to a-factor, full-length PRY3 mRNA
declines and concomitantly a shorter transcript
appears, which has 50 start 452 nucleotides inside the
open reading frame [46]. The repression of the full-
length transcript depends on the pheromone-induced
transcription factor Ste12, which binds the promoter
of PRY3 close to the TATA box thereby impeding its
proper recognition [46]. Expression of both the short
and the long transcripts rely on the daughter cell-speci-
ﬁc transcription factor Ace2, hence the gene is speciﬁ-
cally expressed in daughter cells and may be important
for mother–daughter separation [47,48]. Phenotypi-
cally, overexpression of Pry3 renders cells more resis-
tant to organic solvents and they display a strongly
reduced mating efﬁciency [46,49]. The precise function
of Pry3 in the mating reaction and the role of the
CAP domain in that function, however, remains to be
deﬁned. However, given that this complex order of
events requires remodeling of the cell wall and fusion
of the two plasma membranes, the hypothesis that the
lipid-binding function of the CAP domain of Pry3
may be involved in some of these events is test worthy.
CAP proteins in pathogen defense
The plant PR-1, one of the three founding members of
the CAP superfamily is synthesized in response to
infections with pathogens [5,6]. Expression of PR-1 in
yeast mutants lacking their endogenous CAP proteins
rescues their block in sterol export and puriﬁed PR-1
binds sterols in vitro. Remarkably, this sterol-binding
activity is important to protect plants from oomycetes,
an important class of sterol-auxotrophic plant patho-
gens [50]. Puriﬁed PR-1 inhibits growth of the sterol
auxotroph Phytophthora brassicae in vitro. This growth
inhibition was released if either a mutant version of
PR-1 that cannot bind sterols was used in the assay or
when the growth media was supplemented with an
excess of sterols, thus indicating that the growth inhi-
bition of oomycetes is likely due to sterol sequestration
by PR-1 [50,51].
Taken together available data on the mode of
action of members of this huge family of proteins
support a model in which these proteins act to bind
and sequester small hydrophobic compounds such as
sterols, fatty acids, and even eicosanoid-derived
immune modulatory signals to suppress the immune
response of the host. They neutralize the action of
membrane perturbing antimicrobial compounds, such
as eugenol, or sequester sterols from sterol-auxo-
trophic pathogens. In any case, CAP proteins are
secreted and produced to which might either be
(infective agents, cancer cells, or plants under attack).
promote proliferation and well-being of the producer,
infective agents, cancer cells or plants under attack.
The challenge now will be to actually identify the
chemical nature of the ligand that these proteins bind
and sequester under their speciﬁc physiological
conditions.
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